RU2002117419A - 4-pyridinyl-N-acyl-L-phenylalanines - Google Patents
4-pyridinyl-N-acyl-L-phenylalaninesInfo
- Publication number
- RU2002117419A RU2002117419A RU2002117419/04A RU2002117419A RU2002117419A RU 2002117419 A RU2002117419 A RU 2002117419A RU 2002117419/04 A RU2002117419/04 A RU 2002117419/04A RU 2002117419 A RU2002117419 A RU 2002117419A RU 2002117419 A RU2002117419 A RU 2002117419A
- Authority
- RU
- Russia
- Prior art keywords
- ness
- alkyl
- hydrogen
- compound according
- formula
- Prior art date
Links
- 125000000217 alkyl group Chemical group 0.000 claims 69
- 229910052739 hydrogen Inorganic materials 0.000 claims 59
- 239000001257 hydrogen Substances 0.000 claims 59
- 150000001875 compounds Chemical class 0.000 claims 56
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 41
- 125000003118 aryl group Chemical group 0.000 claims 21
- 229910052736 halogen Inorganic materials 0.000 claims 21
- 150000002367 halogens Chemical class 0.000 claims 21
- 125000003545 alkoxy group Chemical group 0.000 claims 18
- 150000002431 hydrogen Chemical class 0.000 claims 18
- -1 perfluoro Chemical group 0.000 claims 13
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 8
- 125000001589 carboacyl group Chemical group 0.000 claims 7
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 5
- 239000011780 sodium chloride Substances 0.000 claims 5
- IBAZQIKVHCLTHH-SFHVURJKSA-N (2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[4-[1,6-dimethyl-2-oxo-4-(trifluoromethyl)pyridin-3-yl]phenyl]propanoic acid Chemical compound O=C1N(C)C(C)=CC(C(F)(F)F)=C1C(C=C1)=CC=C1C[C@@H](C(O)=O)NC(=O)C1=C(Cl)C=CC=C1Cl IBAZQIKVHCLTHH-SFHVURJKSA-N 0.000 claims 4
- 108010008212 Integrin alpha4beta1 Proteins 0.000 claims 4
- 125000005196 alkyl carbonyloxy group Chemical group 0.000 claims 4
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims 4
- UJSGTHFOHGFQMM-KRWDZBQOSA-N (2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[4-[1,4-dimethyl-2-oxo-6-(trifluoromethyl)pyridin-3-yl]phenyl]propanoic acid Chemical compound C1=C(C(F)(F)F)N(C)C(=O)C(C=2C=CC(C[C@H](NC(=O)C=3C(=CC=CC=3Cl)Cl)C(O)=O)=CC=2)=C1C UJSGTHFOHGFQMM-KRWDZBQOSA-N 0.000 claims 3
- CGDRAVDJURFDMP-SFHVURJKSA-N (2S)-2-[(2-chloro-6-methylbenzoyl)amino]-3-[4-[1,4-dimethyl-2-oxo-6-(trifluoromethyl)pyridin-3-yl]phenyl]propanoic acid Chemical compound CC1=CC=CC(Cl)=C1C(=O)N[C@H](C(O)=O)CC1=CC=C(C=2C(N(C)C(=CC=2C)C(F)(F)F)=O)C=C1 CGDRAVDJURFDMP-SFHVURJKSA-N 0.000 claims 3
- 208000006673 Asthma Diseases 0.000 claims 3
- 206010061218 Inflammation Diseases 0.000 claims 3
- 206010039073 Rheumatoid arthritis Diseases 0.000 claims 3
- 125000003435 aroyl group Chemical group 0.000 claims 3
- 125000004432 carbon atoms Chemical group C* 0.000 claims 3
- 229910052801 chlorine Inorganic materials 0.000 claims 3
- 239000000460 chlorine Substances 0.000 claims 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims 3
- 230000004054 inflammatory process Effects 0.000 claims 3
- 201000006417 multiple sclerosis Diseases 0.000 claims 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 3
- 229910052760 oxygen Inorganic materials 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 229910052717 sulfur Inorganic materials 0.000 claims 3
- APVDSPBBKYMHQH-IBGZPJMESA-N (2S)-2-[(2-chloro-6-methylbenzoyl)amino]-3-[4-[1,6-dimethyl-2-oxo-4-(trifluoromethyl)pyridin-3-yl]phenyl]propanoic acid Chemical compound CC1=CC=CC(Cl)=C1C(=O)N[C@H](C(O)=O)CC1=CC=C(C=2C(N(C)C(C)=CC=2C(F)(F)F)=O)C=C1 APVDSPBBKYMHQH-IBGZPJMESA-N 0.000 claims 2
- 102100019577 VCAM1 Human genes 0.000 claims 2
- 108010000134 Vascular Cell Adhesion Molecule-1 Proteins 0.000 claims 2
- 125000004644 alkyl sulfinyl group Chemical group 0.000 claims 2
- 125000004414 alkyl thio group Chemical group 0.000 claims 2
- 125000004429 atoms Chemical group 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 2
- 125000005842 heteroatoms Chemical group 0.000 claims 2
- 230000000968 intestinal Effects 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 230000001404 mediated Effects 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 230000001575 pathological Effects 0.000 claims 2
- WVTAFEUTNNWYQO-SFHVURJKSA-N (2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[4-(1,4-dimethyl-2-oxopyridin-3-yl)phenyl]propanoic acid Chemical compound C1=CN(C)C(=O)C(C=2C=CC(C[C@H](NC(=O)C=3C(=CC=CC=3Cl)Cl)C(O)=O)=CC=2)=C1C WVTAFEUTNNWYQO-SFHVURJKSA-N 0.000 claims 1
- BWJPNBIUIHZRPA-FQEVSTJZSA-N (2S)-2-[(2-bromo-5-methoxybenzoyl)amino]-3-[4-(1-methyl-2-oxopyridin-3-yl)phenyl]propanoic acid Chemical compound COC1=CC=C(Br)C(C(=O)N[C@@H](CC=2C=CC(=CC=2)C=2C(N(C)C=CC=2)=O)C(O)=O)=C1 BWJPNBIUIHZRPA-FQEVSTJZSA-N 0.000 claims 1
- SQKRZWKSHPTTCU-IBGZPJMESA-N (2S)-2-[(2-chloro-6-methylbenzoyl)amino]-3-[4-(1,4-dimethyl-2-oxopyridin-3-yl)phenyl]propanoic acid Chemical compound CC1=CC=CC(Cl)=C1C(=O)N[C@H](C(O)=O)CC1=CC=C(C=2C(N(C)C=CC=2C)=O)C=C1 SQKRZWKSHPTTCU-IBGZPJMESA-N 0.000 claims 1
- VNNBTSYVKBFTEF-IBGZPJMESA-N (2S)-2-[(2-chloro-6-methylbenzoyl)amino]-3-[4-(1-methyl-2-oxopyridin-3-yl)phenyl]propanoic acid Chemical compound CC1=CC=CC(Cl)=C1C(=O)N[C@H](C(O)=O)CC1=CC=C(C=2C(N(C)C=CC=2)=O)C=C1 VNNBTSYVKBFTEF-IBGZPJMESA-N 0.000 claims 1
- IMOMSSUKSKNQTH-IBGZPJMESA-N (2S)-2-[(2-chloro-6-methylbenzoyl)amino]-3-[4-(5-chloro-1-methyl-2-oxopyridin-3-yl)phenyl]propanoic acid Chemical compound CC1=CC=CC(Cl)=C1C(=O)N[C@H](C(O)=O)CC1=CC=C(C=2C(N(C)C=C(Cl)C=2)=O)C=C1 IMOMSSUKSKNQTH-IBGZPJMESA-N 0.000 claims 1
- GKDKCVPKWZWHID-VWLOTQADSA-N (2S)-3-[4-(1-benzyl-5-chloro-2-oxopyridin-3-yl)phenyl]-2-[(2-chloro-6-methylbenzoyl)amino]propanoic acid Chemical compound CC1=CC=CC(Cl)=C1C(=O)N[C@H](C(O)=O)CC1=CC=C(C=2C(N(CC=3C=CC=CC=3)C=C(Cl)C=2)=O)C=C1 GKDKCVPKWZWHID-VWLOTQADSA-N 0.000 claims 1
- SYOKUINFRLDEJW-FQEVSTJZSA-N (2S)-3-[4-(5-chloro-1-methyl-2-oxopyridin-3-yl)phenyl]-2-[[1-(2-methoxyethyl)cyclopentanecarbonyl]amino]propanoic acid Chemical compound N([C@@H](CC=1C=CC(=CC=1)C=1C(N(C)C=C(Cl)C=1)=O)C(O)=O)C(=O)C1(CCOC)CCCC1 SYOKUINFRLDEJW-FQEVSTJZSA-N 0.000 claims 1
- CBPNUSPLCWQDTD-NRFANRHFSA-N (2S)-3-[4-[1,6-dimethyl-2-oxo-4-(trifluoromethyl)pyridin-3-yl]phenyl]-2-[(2-ethyl-6-methylbenzoyl)amino]propanoic acid Chemical compound CCC1=CC=CC(C)=C1C(=O)N[C@H](C(O)=O)CC1=CC=C(C=2C(N(C)C(C)=CC=2C(F)(F)F)=O)C=C1 CBPNUSPLCWQDTD-NRFANRHFSA-N 0.000 claims 1
- QWKCHTVWYPJVFD-QFIPXVFZSA-N (2S)-3-[4-[1,6-dimethyl-2-oxo-4-(trifluoromethyl)pyridin-3-yl]phenyl]-2-[(2-methyl-6-propan-2-ylbenzoyl)amino]propanoic acid Chemical compound CC(C)C1=CC=CC(C)=C1C(=O)N[C@H](C(O)=O)CC1=CC=C(C=2C(N(C)C(C)=CC=2C(F)(F)F)=O)C=C1 QWKCHTVWYPJVFD-QFIPXVFZSA-N 0.000 claims 1
- PBIAFEAQIMQDNE-FQEVSTJZSA-N (2S)-3-[4-[1,6-dimethyl-2-oxo-4-(trifluoromethyl)pyridin-3-yl]phenyl]-2-[[1-(2-methoxyethyl)cyclopentanecarbonyl]amino]propanoic acid Chemical compound N([C@@H](CC=1C=CC(=CC=1)C=1C(N(C)C(C)=CC=1C(F)(F)F)=O)C(O)=O)C(=O)C1(CCOC)CCCC1 PBIAFEAQIMQDNE-FQEVSTJZSA-N 0.000 claims 1
- 210000000936 Intestines Anatomy 0.000 claims 1
- 125000005236 alkanoylamino group Chemical group 0.000 claims 1
- 125000003342 alkenyl group Chemical group 0.000 claims 1
- 125000004849 alkoxymethyl group Chemical group 0.000 claims 1
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 claims 1
- 125000003710 aryl alkyl group Chemical group 0.000 claims 1
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 125000004494 ethyl ester group Chemical group 0.000 claims 1
- 125000000623 heterocyclic group Chemical group 0.000 claims 1
- 239000000543 intermediate Substances 0.000 claims 1
- 125000004433 nitrogen atoms Chemical group N* 0.000 claims 1
- 230000001681 protective Effects 0.000 claims 1
Claims (56)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16909099P | 1999-12-06 | 1999-12-06 | |
US60/169,090 | 1999-12-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2002117419A true RU2002117419A (en) | 2003-12-20 |
RU2270193C2 RU2270193C2 (en) | 2006-02-20 |
Family
ID=22614226
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2002117419/04A RU2270193C2 (en) | 1999-12-06 | 2000-11-29 | 4-pyridinyl-n-acyl-l-phenylalanines |
Country Status (34)
Country | Link |
---|---|
EP (1) | EP1244625B1 (en) |
JP (2) | JP2003516392A (en) |
KR (1) | KR100492111B1 (en) |
CN (1) | CN1196682C (en) |
AR (1) | AR031083A1 (en) |
AT (1) | ATE297895T1 (en) |
AU (1) | AU779063B2 (en) |
BR (1) | BR0016172A (en) |
CA (1) | CA2392566A1 (en) |
CO (1) | CO5080771A1 (en) |
CZ (1) | CZ20022352A3 (en) |
DE (1) | DE60020883T2 (en) |
DK (1) | DK1244625T3 (en) |
ES (1) | ES2243335T3 (en) |
GC (1) | GC0000214A (en) |
HK (1) | HK1053470A1 (en) |
HR (1) | HRP20020467A2 (en) |
HU (1) | HUP0203735A3 (en) |
IL (2) | IL149622A0 (en) |
JO (1) | JO2281B1 (en) |
MA (1) | MA26849A1 (en) |
MX (1) | MXPA02005240A (en) |
MY (1) | MY128003A (en) |
NO (1) | NO322910B1 (en) |
NZ (1) | NZ518888A (en) |
PE (1) | PE20010960A1 (en) |
PL (1) | PL364814A1 (en) |
PT (1) | PT1244625E (en) |
RU (1) | RU2270193C2 (en) |
TW (1) | TWI276629B (en) |
UY (1) | UY26470A1 (en) |
WO (1) | WO2001042215A1 (en) |
YU (1) | YU40502A (en) |
ZA (1) | ZA200203762B (en) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6960597B2 (en) | 2000-06-30 | 2005-11-01 | Orth-Mcneil Pharmaceutical, Inc. | Aza-bridged-bicyclic amino acid derivatives as α4 integrin antagonists |
MXPA03001495A (en) | 2000-08-18 | 2003-06-06 | Ajinomoto Kk | NEW PHENYLALANINE DERIVATIVES. |
DE60124573T2 (en) * | 2000-09-29 | 2007-06-21 | Ajinomoto Co., Inc. | NEW PHENYLALANINE DERIVATIVES |
EP1454898A4 (en) * | 2001-12-13 | 2006-12-13 | Ajinomoto Kk | Novel phenylalanine derivative |
US7482366B2 (en) | 2001-12-21 | 2009-01-27 | X-Ceptor Therapeutics, Inc. | Modulators of LXR |
CA2469435A1 (en) | 2001-12-21 | 2003-07-24 | X-Ceptor Therapeutics, Inc. | Modulators of lxr |
AU2004303696B2 (en) | 2003-12-22 | 2011-03-31 | Ea Pharma Co., Ltd. | Novel phenylalanine derivative |
US7618981B2 (en) * | 2004-05-06 | 2009-11-17 | Cytokinetics, Inc. | Imidazopyridinyl-benzamide anti-cancer agents |
CA2576647C (en) * | 2004-08-16 | 2011-12-13 | Merck & Co., Inc. | Vla-4 antagonists |
JP4784224B2 (en) | 2004-09-24 | 2011-10-05 | 味の素株式会社 | Glycosyl transfer method and glycosyltransferase |
EP2007392A4 (en) * | 2006-02-28 | 2010-04-07 | Elan Pharm Inc | Methods of treating inflammatory and autoimmune diseases with alpha-4 inhibitory compounds |
AR060901A1 (en) * | 2006-05-12 | 2008-07-23 | Jerini Ag | HETEROCICLICAL COMPOUNDS FOR THE INHIBITION OF INTEGRINS AND USE OF THESE |
EP2124996A4 (en) | 2007-02-20 | 2010-03-24 | Merrimack Pharmaceuticals Inc | Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist |
PL2288715T3 (en) | 2008-04-11 | 2015-03-31 | Merrimack Pharmaceuticals Inc | Human serum albumin linkers and conjugates thereof |
KR101747709B1 (en) * | 2009-07-23 | 2017-06-15 | 바이엘 인텔렉쳐 프로퍼티 게엠베하 | Novel alkoxyenones and enaminoketones and a method for the production thereof |
US8877815B2 (en) | 2010-11-16 | 2014-11-04 | Novartis Ag | Substituted carbamoylcycloalkyl acetic acid derivatives as NEP |
JP6159740B2 (en) * | 2012-01-27 | 2017-07-05 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | Integrin antagonist conjugates for targeted delivery to cells expressing VLA-4 |
CA2913791A1 (en) * | 2013-06-11 | 2014-12-18 | Receptos, Inc. | Novel glp-1 receptor modulators |
CA3013433A1 (en) | 2016-02-05 | 2017-08-10 | Ea Pharma Co., Ltd. | Sulfonamide derivative and pharmaceutical composition containing same |
CN112969504B (en) | 2018-10-30 | 2024-04-09 | 吉利德科学公司 | Compounds for inhibiting alpha 4 beta 7 integrin |
SG11202103484RA (en) | 2018-10-30 | 2021-05-28 | Gilead Sciences Inc | Quinoline derivatives as alpha4beta7 integrin inhibitors |
AU2019373244B2 (en) | 2018-10-30 | 2022-05-26 | Gilead Sciences, Inc. | Imidazopyridine derivatives as alpha4beta7 integrin inhibitors |
CN112996786A (en) | 2018-10-30 | 2021-06-18 | 吉利德科学公司 | Compounds for inhibiting alpha 4 beta 7 integrins |
KR20220047323A (en) | 2019-08-14 | 2022-04-15 | 길리애드 사이언시즈, 인코포레이티드 | Compounds for Inhibiting Alpha 4 Beta 7 Integrin |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002512625A (en) * | 1997-05-29 | 2002-04-23 | メルク エンド カンパニー インコーポレーテッド | Heterocyclic amide compounds as cell adhesion inhibitors |
ATE318841T1 (en) * | 1997-05-29 | 2006-03-15 | Merck & Co Inc | BIARYLALKANEOUS ACIDS USED AS CELL ADHESION INHIBITORS |
US6197794B1 (en) * | 1998-01-08 | 2001-03-06 | Celltech Therapeutics Limited | Phenylalanine derivatives |
MY153569A (en) * | 1998-01-20 | 2015-02-27 | Mitsubishi Tanabe Pharma Corp | Inhibitors of ?4 mediated cell adhesion |
US6329372B1 (en) * | 1998-01-27 | 2001-12-11 | Celltech Therapeutics Limited | Phenylalanine derivatives |
EP1056714B1 (en) * | 1998-02-26 | 2004-08-11 | Celltech Therapeutics Limited | Phenylalanine derivatives as inhibitors of alpha4 integrins |
GB9811159D0 (en) * | 1998-05-22 | 1998-07-22 | Celltech Therapeutics Ltd | Chemical compounds |
WO2000037429A2 (en) * | 1998-12-22 | 2000-06-29 | Tanabe Seiyaku Co., Ltd. | INHIBITORS OF α4β1 MEDIATED CELL ADHESION |
JP2002535304A (en) * | 1999-01-22 | 2002-10-22 | エラン ファーマシューティカルズ,インコーポレイテッド | Polycyclic compounds inhibiting leukocyte adhesion mediated by VAL-4 |
-
2000
- 2000-11-29 WO PCT/EP2000/011979 patent/WO2001042215A1/en active IP Right Grant
- 2000-11-29 RU RU2002117419/04A patent/RU2270193C2/en not_active IP Right Cessation
- 2000-11-29 JO JO2000189A patent/JO2281B1/en active
- 2000-11-29 ES ES00985117T patent/ES2243335T3/en not_active Expired - Lifetime
- 2000-11-29 CA CA002392566A patent/CA2392566A1/en not_active Abandoned
- 2000-11-29 DE DE60020883T patent/DE60020883T2/en not_active Expired - Lifetime
- 2000-11-29 AU AU21639/01A patent/AU779063B2/en not_active Ceased
- 2000-11-29 KR KR10-2002-7007201A patent/KR100492111B1/en not_active IP Right Cessation
- 2000-11-29 IL IL14962200A patent/IL149622A0/en active IP Right Grant
- 2000-11-29 NZ NZ518888A patent/NZ518888A/en unknown
- 2000-11-29 AT AT00985117T patent/ATE297895T1/en not_active IP Right Cessation
- 2000-11-29 BR BR0016172-1A patent/BR0016172A/en not_active Application Discontinuation
- 2000-11-29 PL PL00364814A patent/PL364814A1/en not_active Application Discontinuation
- 2000-11-29 HU HU0203735A patent/HUP0203735A3/en unknown
- 2000-11-29 CN CNB008164800A patent/CN1196682C/en not_active Expired - Fee Related
- 2000-11-29 YU YU40502A patent/YU40502A/en unknown
- 2000-11-29 MX MXPA02005240A patent/MXPA02005240A/en active IP Right Grant
- 2000-11-29 CZ CZ20022352A patent/CZ20022352A3/en unknown
- 2000-11-29 DK DK00985117T patent/DK1244625T3/en active
- 2000-11-29 PT PT00985117T patent/PT1244625E/en unknown
- 2000-11-29 EP EP00985117A patent/EP1244625B1/en not_active Expired - Lifetime
- 2000-11-29 JP JP2001543516A patent/JP2003516392A/en active Pending
- 2000-12-02 GC GCP20001072 patent/GC0000214A/en active
- 2000-12-04 AR ARP000106416A patent/AR031083A1/en not_active Application Discontinuation
- 2000-12-04 MY MYPI20005689A patent/MY128003A/en unknown
- 2000-12-05 UY UY26470A patent/UY26470A1/en not_active Application Discontinuation
- 2000-12-05 TW TW089125889A patent/TWI276629B/en not_active IP Right Cessation
- 2000-12-05 CO CO00092690A patent/CO5080771A1/en unknown
- 2000-12-06 PE PE2000001306A patent/PE20010960A1/en not_active Application Discontinuation
-
2002
- 2002-05-10 ZA ZA200203762A patent/ZA200203762B/en unknown
- 2002-05-13 IL IL149622A patent/IL149622A/en not_active IP Right Cessation
- 2002-05-28 HR HR20020467A patent/HRP20020467A2/en not_active Application Discontinuation
- 2002-06-05 MA MA26672A patent/MA26849A1/en unknown
- 2002-06-05 NO NO20022650A patent/NO322910B1/en unknown
-
2003
- 2003-08-13 HK HK03105803A patent/HK1053470A1/en not_active IP Right Cessation
-
2007
- 2007-10-05 JP JP2007262543A patent/JP2008094842A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2002117419A (en) | 4-pyridinyl-N-acyl-L-phenylalanines | |
RU2002117422A (en) | 4-pyrimidinyl-N-acyl-L-phenylalanines | |
RU2001124596A (en) | Thioamide derivatives | |
RU2468021C2 (en) | Heterocyclic compounds and their application | |
RU2006112593A (en) | 2, 4-DI (HETERO) ARILAMINOPYRIMIDINE DERIVATIVES AS ZAP-70 AND / OR SYK INHIBITORS | |
JP2020504711A5 (en) | ||
RU2413727C2 (en) | Pyrazole derivatives and use thereof as receptor tyrosine kinase inhibitors | |
EP2295057B1 (en) | Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers | |
RU2004134564A (en) | CHEMICAL COMPOUNDS | |
RU2004130488A (en) | Pyrimidine derivatives | |
RU2007134380A (en) | ANTIBACTERIAL PIPERIDINE DERIVATIVES | |
CA2417148A1 (en) | Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation | |
RU2000129148A (en) | DIHYDROPYRIMIDINES | |
CA2415486A1 (en) | Pyramidine derivatives | |
RU2008106058A (en) | Pyridazinone derivatives as thyroid hormone receptor agonists | |
RU2003132687A (en) | TREATMENT OF TYPE 2 DIABETES BY DIPEPTIDYLPEPTIDASE IV INHIBITORS | |
TW200621249A (en) | Substituted amide beta secretase inhibitors | |
RU2004117545A (en) | AMINOPYRIMIDINES AND PYRIDINES | |
RU2003103848A (en) | Pyrimidine derivatives | |
JP2004518723A5 (en) | ||
RU2006133373A (en) | IMIDAZOLINE DERIVATIVES WITH CB1-ANTAGONISTIC ACTIVITY | |
RU2002103876A (en) | AMINOBENZOPHENONES AS INTERLEUKIN IL-1β INHIBITORS AND TUMOR NECROSIS FACTOR TNF-α | |
RU2017131354A (en) | SUBSTITUTED AMINO HEXATURAL SATURATED HETEROALICYCLES AS LONG-TERM DPP-IV INHIBITORS | |
RU2005136131A (en) | PHARMACEUTICAL COMPOSITION CONTAINING A P2X7 RECEPTOR ANTAGONIST AND TUMOR NECROSIS FACTOR | |
RU2006112423A (en) | PHARMACEUTICAL COMPOSITION CONTAINING A P2X RECEPTOR ANTAGONIST AND NESTEROID ANTI-INFLAMMATORY MEDICINE |